Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endologix Inc raises low end of prior FY 2014 revenue outlook to a range in line with analysts' estimates; narrows FY 2014 earnings outlook


Wednesday, 30 Jul 2014 04:06pm EDT 

Endologix Inc:Says it is narrowing its FY 2014 financial guidance, within the previous guidance range.Expects FY 2014 revenue to be in the range of $148 -$152 mln, compared to the previous range of $146 -$152 mln.Expects FY 2014 adjusted net loss per share to be in the range of $(0.27) to $(0.33).Expects FY 2014 adjusted EBITDA per share to be in the range of $(0.10) to $(0.16), compared to the previous range of $(0.04) to $(0.17).FY 2014 revenue of $148 mln, EPS of ($0.28) - Thomson Reuters I/B/E/S. 

Company Quote

14.0
0.15 +1.08%
1:20pm EDT